SCHEMBL5598267

SCHEMBL5598267

O=S(=O)(NCc1ccccc1C(F)(F)F)c1ccc(OC(F)(F)F)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 2/20 0.53
MMP3 P08254 1/20 0.52
KMT2A Q03164 3/20 0.50
GAA P10253 2/20 0.50
FFAR4 Q5NUL3 2/20 0.49
GRIN2B Q13224 1/20 0.47
MEN1 O00255 2/20 0.46
ALDH1A1 P00352 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.44
ADAMTS4 O75173 1/20 0.44
MMP13 P45452 1/20 0.44
SLC22A12 Q96S37 1/20 0.44
CYP19A1 P11511 1/20 0.44
MMP1 P03956 1/20 0.44
MMP2 P08253 1/20 0.44
MMP9 P14780 1/20 0.44
MMP14 P50281 1/20 0.44
ADAM17 P78536 1/20 0.44
MAPT P10636 1/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30927226 0.86 NAMPT (0.56) NAMPTKMT2AGAAFFAR4MEN1
SCHEMBL5598318 0.84 POLB (0.60) NAMPTMMP3KMT2AGAAALDH1A1
SCHEMBL29019312 0.83 KMT2A (0.67) NAMPTKMT2AGAAMEN1ALDH1A1
SCHEMBL5597888 0.82 GAA (0.71) NAMPTKMT2AGAAMEN1ALDH1A1
SCHEMBL26920561 0.81 GAA (0.56) MMP3KMT2AGAAFFAR4MEN1
SCHEMBL18450372 0.80 ALDH1A1 (0.68) NAMPTALDH1A1L3MBTL1CYP19A1
SCHEMBL26921059 0.80 GAA (0.68) MMP3KMT2AGAAMEN1ALDH1A1
SCHEMBL13972863 0.78 NAMPT (0.55) NAMPTKMT2AGAAMEN1ALDH1A1
SCHEMBL13959200 0.78 NAMPT (0.55) NAMPTKMT2AGAAMEN1ALDH1A1
SCHEMBL31017284 0.78 MAPT (0.47) MMP3KMT2AGAAMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1815860-A2 Phosphate transport inhibitors GENZYME CORPORATION (US) 2007-08-08 EP disclosed
EP-1815860-A2 Phosphate transport inhibitors GENZYME CORPORATION (US) 2007-08-08 EP disclosed
US-20070021509-A1 Phosphate transport inhibitors JOZEFIAK THOMAS H 2007-01-25 US disclosed
US-20070021509-A1 Phosphate transport inhibitors JOZEFIAK THOMAS H 2007-01-25 US disclosed
US-20070021509-A1 Phosphate transport inhibitors JOZEFIAK THOMAS H 2007-01-25 US disclosed
US-7119120-B2 Phosphate transport inhibitors GENZYME CORPORATION (US) 2006-10-10 US disclosed
EP-1465638-A2 PHOSPHATE TRANSPORT INHIBITORS GENZYME CORPORATION (US) 2004-10-13 EP disclosed
US-20040019113-A1 Phosphate transport inhibitors GELTEX PHARMACEUTICALS, INC. 2004-01-29 US disclosed
WO-2003057225-A2 PHOSPHATE TRANSPORT INHIBITORS GENZYME CORPORATION (US) 2003-07-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040019113-A1 Phosphate transport inhibitors SLC34A1, SLC34A2, SLC20A1 NAMPT 736/4885MMP3 2678/4885KMT2A 4536/4885
US-20070021509-A1 Phosphate transport inhibitors SLC34A2, SLC34A1, SLC20A1 NAMPT 490/4885MMP3 2445/4885KMT2A 4634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.